Epicrispr Biotechnologies vs Genentech (Roche)
Epicrispr Biotechnologies vs Genentech (Roche), compared side by side on 12 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Epicrispr Biotechnologies is on 62/100 and Genentech (Roche) on Not scored yet.
Where each one leads
Epicrispr Biotechnologies
- agent readiness: 39/100 against 31/100
Genentech (Roche)
- domain rating: 80/100 against 40/100
At a glance
| Measure | Epicrispr Biotechnologies | Genentech (Roche) |
|---|---|---|
| What it is | Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD). | Pioneering biotechnology company focused on discovering, developing, manufacturing, and commercializing medicines to treat patients with serious or life-threatening medical conditions. |
| Category | Biotechnology, Therapeutics, Rare Diseases, Epigenetics | Biotech, Drug Discovery, Genomics, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Biotech |
| Founded | 2020 | 1976 |
| Headquarters | South San Francisco, United States | South San Francisco, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Epicrispr Biotechnologies | Genentech (Roche) |
|---|---|---|
| Employees | 51 | Not published |
| Total funding | $90.0M | Not published |
| Latest round | Series C | Not published |
| LinkedIn followers | 7,025 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Epicrispr Biotechnologies | Genentech (Roche) |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | Not published |
| Traction | 57/100 | Not published |
| Team | 40/100 | Not published |
| Search visibility | 20/100 | Not published |
| Quality | 78/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (31/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 80/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Epicrispr Biotechnologies | Genentech (Roche) |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Jquery |
| Analytics | Google Analytics 4 | Google Tag Manager |
Epicrispr Biotechnologies vs Genentech (Roche): common questions
Which is better, Epicrispr Biotechnologies or Genentech (Roche)?
On our 0-100 score Epicrispr Biotechnologies rates higher (62/100 against Not scored yet). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 12 data points above: read the rows that match what you are buying for.
How do Epicrispr Biotechnologies and Genentech (Roche) compare on the numbers?
Epicrispr Biotechnologies leads on agent readiness (39/100 against 31/100). Genentech (Roche) leads on domain rating (80/100 against 40/100).
Read the full Epicrispr Biotechnologies review and pricing or the Genentech (Roche) review and pricing. You can also browse other Epicrispr Biotechnologies alternatives we track.